Latest news
NextCure - The Pharma LetterThe Pharma Letter · Wed, 05 Aug 2026 13:34:21 GMTMinority Investors Sue Industrial Realty Group Over Timing Of Reverse Merger - BisnowBisnow · Mon, 03 Aug 2026 23:00:45 GMTObsidian raises USD 350m to advance engineered TIL therapy into registration-enabling melanoma trial - AllSciAllSci · Mon, 03 Aug 2026 17:35:22 GMTScancell merges with Nasdaq shell Neuphoria to fund USD 89m Phase III melanoma trial - AllSciAllSci · Fri, 31 Jul 2026 15:25:48 GMTNextCure's Maryland Operation Winds Down in Reverse Merger With San Francisco-Based Avere Therapeutics - biobuzz.iobiobuzz.io · Thu, 30 Jul 2026 20:57:38 GMTInside the deal: Passage Bio weighed 21 merger bids before choosing Remix - bizjournals.combizjournals.com · Thu, 30 Jul 2026 07:00:00 GMTCaldera catches reverse merger mania, plots to go public in deal with Synlogic - FirstWord PharmaFirstWord Pharma · Wed, 29 Jul 2026 18:36:26 GMTLess than year after launch, Caldera lines up $278M financing and Nasdaq debut - bizjournals.combizjournals.com · Wed, 29 Jul 2026 17:22:00 GMT